Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
9
Page:
84-107
Author(s):
M. W. Lawless, S. Norris, K. J. O'Byrne and S. G. Gray
Research Toward Potassium Channels on Tumor Progression
Journal:
Current Topics in Medicinal Chemistry
Volume:
9
Page:
322-329
Author(s):
Zheng Shen, Qian Yang and Qidong You
Murine Models of Vpr-Mediated Pathogenesis
Journal:
Current HIV Research
Volume:
7
Page:
129-135
Author(s):
Alexandra Snyder and Michael J. Ross
Analysis of the Potential for HIV-1 Vpr as an Anti-Cancer Agent
Journal:
Current HIV Research
Volume:
7
Page:
144-152
Author(s):
Karrupiah Muthumani, Vance M. Lambert, Niranjan Y. Sardesai, Jong J. Kim, Richard Heller, David B. Weiner and Kenneth E. Ugen
Development of Multifunctional Nanoparticles for Targeted Drug Delivery and Noninvasive Imaging of Therapeutic Effect
Journal:
Current Drug Discovery Technologies
Volume:
6
Page:
43-51
Author(s):
Hari Krishna Sajja, Michael P. East, Hui Mao, Y. Andrew Wang, Shuming Nie and Lily Yang
The Role of the RhoA/rho-kinase Pathway in Pulmonary Hypertension
Journal:
Current Drug Discovery Technologies
Volume:
6
Page:
59-71
Author(s):
Bobby D. Nossaman and Philip J. Kadowitz
Notch Inhibitors as a New Tool in the War on Cancer: A Pathway to Watch
Journal:
Current Pharmaceutical Biotechnology
Volume:
10
Page:
154-160
Author(s):
Benjamin Purow
Targeting the Immune System in Cancer
Journal:
Current Pharmaceutical Biotechnology
Volume:
10
Page:
166-184
Author(s):
Devyani Chaudhuri, Robert Suriano, Abraham Mittelman and Raj K. Tiwari
Targeting the Tumor Stroma in Cancer Therapy
Journal:
Current Pharmaceutical Biotechnology
Volume:
10
Page:
185-191
Author(s):
Kevin Anton and John Glod
Pleiotropic Effects of Fenofibrate
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
517-528
Author(s):
V. Tsimihodimos, E. Liberopoulos and M. Elisaf